Collectively, our study suggests that skimmianine may alleviate cerebral ischemia/reperfusion injury by modulating immune and inflammatory responses, as well as antioxidant mechanisms mediated by IBA-1, IL-6, and NF-κB. Here, NFKB1 is linked to Cerebral ischemia.